Sanofi Q3 2013 - Interview with CFO Jérôme Contamine

PARIS--()--Sanofi, a global and diversified healthcare leader, reports results for the third-quarter of 2013. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on results and outlook.

Watch video interview and read transcript:

http://www.eurobusinessmedia.com/Sanofi-Q3-2013-Interview-with-CFO-Jerome-Contamine?utm_source=ceo-direct&utm_medium=bwl

Topics covered in the interview include:

- Q3 2013 Results

- Diabetes

- Vaccines

- Emerging Markets

- Consumer Healthcare

- Genzyme

- Animal Health

- Alirocumab

- Guidance

About Sanofi

Sanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Company website: www.sanofi.com

Contacts

Sanofi
Investor Relations
Sébastien Martel, +33 1 53 77 45 45
IR@sanofi.com
or
Media Relations
+33 1 53 77 45 02
MR@sanofi.com

Release Summary

Paris, October 30, 2013 — Sanofi, a global and diversified healthcare leader, reports results for the third-quarter of 2013. Jérôme Contamine, CFO of Sanofi, comments on results and outlook.

Sharing

Contacts

Sanofi
Investor Relations
Sébastien Martel, +33 1 53 77 45 45
IR@sanofi.com
or
Media Relations
+33 1 53 77 45 02
MR@sanofi.com